Rapid Therapeutic Science Laboratories, Inc. (RTSL)
OTCMKTS: RTSL · Delayed Price · USD
0.0050
0.00 (0.00%)
Apr 10, 2024, 11:09 AM EDT - Market closed

RTSL Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 202220212019201720162015201420132012
Cash & Equivalents
-0.380.1900.010.010.010.010.020.03
Cash & Cash Equivalents
-0.380.1900.010.010.010.010.020.03
Cash Growth
-14329.09%-89.15%66.29%-19.95%-7.44%-46.21%-41.99%-
Receivables
0.3800000000
Inventory
0.180.180.01000000
Other Current Assets
0.060.05-0.010.010000-
Total Current Assets
0.230.4200.020.010.010.010.020.04
Property, Plant & Equipment
1.851.610000000
Intangible Assets
0.170.170.3000000
Total Long-Term Assets
2.021.780.3000000
Total Assets
2.252.200.030.010.010.010.020.04
Accounts Payable
0.890.470.020.0100000
Deferred Revenue
00.050.03000000
Current Debt
3.41.460.740.6500000
Other Current Liabilities
0.671.090.180.030.030.0100-
Total Current Liabilities
4.973.050.970.690.030.01000
Long-Term Debt
0.430.532.22.200000
Other Long-Term Liabilities
00000000-
Total Long-Term Liabilities
0.430.532.22.200000
Total Liabilities
5.43.583.172.890.030.01000
Total Debt
3.831.992.942.850.030.01000
Debt Growth
92.94%-32.49%3.36%9384.45%200.00%----
Common Stock
0.010.190000000
Retained Earnings
-10.32-8.52-2.98-2.63-0.08-0.05-0.04-0.03-0.01
Comprehensive Income
000-0.1900000
Shareholders' Equity
-3.14-1.38-3.17-2.86-0.02-00.010.020.04
Total Liabilities and Equity
2.252.200.030.010.010.010.020.04
Net Cash / Debt
-4.21-1.79-2.94-2.83-0.02-00.010.02-
Net Cash / Debt Growth
-------46.21%--
Net Cash Per Share
-0.54-0.24-61.04-28.72-0.21-0.010.090.17-
Working Capital
-4.73-2.63-0.97-0.67-0.02-00.010.020.04
Book Value Per Share
-0.41-0.18-65.79-29.02-0.21-0.010.100.21-
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.